成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天
Wuhan Jingkangen Biomedical Technology Co., Ltd
Firmenname:
Wuhan Jingkangen Biomedical Technology Co., Ltd
Telefon:
13720134139 +86 -0-15871494362
E-Mail:
orders@jknbiochem.com
Nationalit?t:
China
URL:
www.jknbiochem.com
Produkte insgesamt:
5822
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
Produktkatalog
Andarine/S-4
401900-40-1
C19H18F3N3O6
YK11
431579-34-9
C25H34O6
Ibutamoren mesylate/MK677
159752-10-0
C28H40N4O8S2
LGD3033
917891-35-1
C16H14ClF3N2O
SR9009
1379686-30-2
C20H24ClN3O4S
Vosilasarm/RAD140
1182367-47-0
C20H16ClN5O2
Cetuximab
205923-56-4
C107H179N35O36S7
LGD4033
1165910-22-4
C14H12F6N2O
Maribavir
176161-24-3
C15H19Cl2N3O4
Acadesine
5-Amino-1-β-D-ribofuranosyl-1H-imidazol-4-carboxamid
2627-69-2
C9H14N4O5
Cardarine/GW501516
317318-70-0
C21H18F3NO3S2
Enobosarm/MK2866
841205-47-8
C19H14F3N3O3
Oportuzumab Monatox
945228-48-8
Tremelimumab
745013-59-6
Tucotuzumab Celmoleukin
339986-90-2
Etaracizumab
892553-42-3
Iratumumab
640735-09-7
Volociximab
558480-40-3
notuzumab
635715-01-4
Bapineuzumab
648895-38-9
Panobacumab
885053-97-4
Otelixizumab
881191-44-2
Obinutuzumab
949142-50-1
Denosumab
615258-40-7
C6404H9912N1724O2004S50
Yttrium (90Y) Tacatuzumab Tetraxetan
476413-07-7
Raxibacumab
565451-13-0
Pagibaximab
595566-61-3
Canakinumab
914613-48-2
Citatuzumab Bogatox
945228-49-9
Besilesomab
537694-98-7
Epitumomab
372075-37-1
Ibalizumab
680188-33-4
Alacizumab
934216-54-3
Fresolimumab
948564-73-6
Ustekinumab
815610-63-0
Infliximab
170277-31-3
Lumiliximab
357613-86-6
Research Grade Clenoliximab
182912-58-9
Ganitumab
905703-97-1
Bertilimumab
375348-49-5
Briakinumab
339308-60-0
Mapatumumab
658052-09-6
ofatumumab
679818-59-8
Ertumaxomab
509077-99-0
Ipilimumab
477202-00-9
Metelimumab
272780-74-2
Regavirumab
153101-26-9
Conatumumab
896731-82-1
Research Grade Lerdelimumab
285985-06-0
Stamulumab
705287-60-1
Zanolimumab
652153-01-0
Tenatumomab
1412891-40-7
Anrukinzumab
910649-32-0
Research Grade Camidanlumab
921618-45-3
Tigatuzumab
918127-53-4
Efungumab
762260-74-2
Research Grade Golimumab
476181-74-5
Galiximab
357613-77-5
Keliximab
174722-30-6
Research Grade Priliximab
147191-91-1
Tralokinumab
1044515-88-9
Adecatumumab
503605-66-1
Tuvirumab
138660-97-6
ocrelizumab
637334-45-3
C19H16N2O5
Research Grade J695
Research Grade Otilimab
1638332-55-4
Zalutumumab
667901-13-5
Racotumomab
946832-34-4
Lexatumumab
845816-02-6
Nebacumab
138661-01-5
Catumaxomab
509077-98-9
Research Grade HuCC49
823788-82-5
Panitumumab
339177-26-3
Gantenerumab
1043556-46-2
Tanezumab
880266-57-9
Dacetuzumab
880486-59-9
Cixutumumab
947687-12-9
Lemalesomab
250242-54-7
Ecromeximab
292819-64-8
Farletuzuma
896723-44-7
Research Grade Bivatuzumab
reslizumab
241473-69-8
Research Grade Pintumomab
SU5408
15966-93-5
C18H18N2O3
Pritumumab
499212-74-7
Tefibazumab
521079-87-8
Libivirumab
569658-79-3
Belimumab
356547-88-1
Exbivirumab
569658-80-6
Elsilimomab
468715-71-1
Urtoxazumab
502496-16-4
Robatumumab
934235-44-6
Elotuzumab
915296-00-3
Teneliximab
395639-53-9
Research Grade Taplitumomab
Erlizumab
211323-03-4
Vapaliximab
336801-86-6
Figitumumab
943453-46-1
Research Grade Anatumomab
Research Grade Sibrotuzumab
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
Copyright 2019 ? ChemicalBook. All rights reserved